Minnesota lab directors are defending their COVID-19 diagnostic tests amid criticism that they are too broad and find insignificant viral material in nasal and saliva samples from some people who aren't infectious.
Critics have questioned how all positive results can be treated the same when some require more rounds, called cycles, of testing and the amplifying of millions more copies of DNA to find genetic proof of the COVID-19 virus.
A Harvard University epidemiologist recently suggested that positives produced with more than 30 cycles are unlikely to find infectious patients, but a leader of Minnesota's public health lab said there is no convincing proof and that her lab is confident in the federally required cycle threshold (CT) of 38 for its COVID-19 test.
"It's a qualitative test — it's positive or negative," said Sara Vetter, interim assistant division director of Minnesota's public health laboratory, which has processed 60,000 COVID-19 tests.
"A [higher or lower] cycle threshold can indicate how much virus is in your sample, but we really don't know enough about what that means for infectivity" in patients.
PCR testing was a breakthrough three decades ago for its ultrasensitive detection of viruses such as measles and HIV by isolating and then replicating genetic material from patient samples. Among other things, it replaced the slow and even hazardous process of diagnosing infections by growing viral cultures themselves — which can happen only in high-security labs when dealing with more dangerous viruses such as SARS-CoV-2.
High-cycle thresholds and the potential detection of low virus levels in specimens has long been understood in PCR testing. Each cycle doubles the amplification of genetic material and increases the chance of finding low virus levels or even fragments of dead virus.
But the PCR test for COVID-19 has taken on heightened scrutiny because the screening of thousands of COVID-19 cases has resulted in financially crippling restrictions on businesses and lives.